{"infobox":{"dc_creator":"WooScraper_v1","dc_date_year":2021,"dc_description":"Advies van de Gezondheidsraad over de inzet van COVID-19 vaccin AstraZeneca bij verschillende doelgroepen die in aanmerking komen voor vaccinatie.","dc_identifier":"nl.mnre1025.2j.2021.490","dc_publisher":"mnre1025","dc_publisher_name":"Ministerie Van Volksgezondheid, Welzijn En Sport","dc_source":"https://open.overheid.nl/Details/ronl-079e736e-5d80-4232-a0ab-138070ad37d8/1","dc_title":"Advies COVID-19-vaccinatie AstraZeneca-vaccin","dc_type":"2j","dc_type_description":"2j - Onderzoek","foi_decisionDate":"2021-02-03","foi_extraMetadata":{},"foi_fairiscoreVersions":{"v1":1,"v2":1},"foi_files":[{"dc_format":"application/pdf","dc_identifier":"nl.mnre1025.2j.2021.490.doc.1","dc_source":"https://open.overheid.nl/documenten/ronl-079e736e-5d80-4232-a0ab-138070ad37d8/pdf","dc_title":"covid-19-vaccinatie-astrazeneca-vaccin","dc_type":"bijlage","foi_fairiscoreVersions":{"v1":1,"v2":1},"foi_fileName":"covid-19-vaccinatie-astrazeneca-vaccin.pdf","foi_nrPages":26}],"foi_isWoo":"Ja","foi_nrDocuments":1,"foi_nrPagesInDossier":26,"foi_page_title":"Onderzoek Ministerie Van Volksgezondheid, Welzijn En Sport","foi_publishedDate":"2021-02-05","foi_retrievedDate":"2024-10-03","tooiwl_topic":"gezondheidsrisico's","tooiwl_type":"c_fdaee95e"},"resource":"nl.mnre1025.2j.2021.490"}